Autori: Bril Vera
Naslov | Long-term safety and tolerability of hyaluronidase-facilitated subcutaneous immunoglobulin 10% as maintenance therapy for chronic inflammatory demyelinating polyradiculoneuropathy: Results from the ADVANCE-CIDP 3 trial (Article; Early Access) |
Autori | Hadden Robert DM Andersen Henning Bril Vera Basta Ivana Z Rejdak Konrad Duff Kim Greco Erin Hasan Shabbir Anderson Smits Colin Ay Hakan |
Info | JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, (2024), vol. br. , str. - |
Projekat | Takeda Development Center Americas, Inc.; Takeda Development Center Americas, Inc. - Takeda Pharmaceuticals International AG |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: |
|
Naslov | Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 10% for CIDP: Final Results from a Long-Term Safety and Tolerability Study (Meeting Abstract) |
Autori | Hadden Robert DM Andersen Henning Bril Vera Basta Ivana Z Rejdak Konrad Duff Kim Greco Erin Hasan Shabbir Anderson Smits Colin Ay Hakan |
Info | JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, (2024), vol. 29 br. , Suppl. 3, str. S78-S79 |
Ispravka | Web of Science Elečas Rang časopisa |
|
Naslov | Long-term safety, tolerability, and efficacy of efgartigimod in patients with generalized myasthenia gravis: Concluding analyses from the ADAPT plus study (Meeting Abstract) |
Autori | Bril Vera ... Peric Stojan Z ![]() |
Info | JOURNAL OF THE NEUROLOGICAL SCIENCES, (2023), vol. 455 br. , Suppl. S, str. - |
Ispravka | Web of Science Članak Elečas Rang časopisa |
|
Naslov | Facilitated subcutaneous immunoglobulin 10% for CIDP: interim results from a long-term safety and tolerability study (Meeting Abstract) |
Autori | Hadden R Andersen H Bril Vera Basta Ivana Z Rejdak Konrad Djordjevic Goran D Greco E Hasan S French J Yel L Ay H |
Info | EUROPEAN JOURNAL OF NEUROLOGY, (2023), vol. 30 br. , Suppl. 1, str. 286-286 |
Projekat | Takeda Development Center Americas, Inc./Takeda Pharmaceuticals International AG |
Ispravka | Web of Science Elečas Rang časopisa |
|
Naslov | Long-Term Assessment of Efgartigimod in Patients with Generalised Myasthenia Gravis: Adapt Plus Study Interim Results (Meeting Abstract) |
Autori | Jacob Saiju Howard James F Jr Bril Vera Peric Stojan Z ![]() |
Info | JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, (2022), vol. 93 br. 9, str. - |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
|
Naslov | Efficacy, Safety, and Tolerability of Efgartigimod in Acetylcholine Receptor Autoantibody Seronegative Patients with Generalized Myasthenia Gravis: Integrated Interim Analysis of the Adapt and Adapt plus Studies (Meeting Abstract) |
Autori | Howard James F Jr Bril Vera Tuan Vu Karam Chafic Peric Stojan Z ![]() |
Info | MUSCLE & NERVE, (2022), vol. 65 br. , Suppl. 1, str. S13-S14 |
Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
Naslov | Long-Term Safety, Tolerability, and Efficacy of Efgartigimod in Patients with Generalized Myasthenia Gravis: Interim Results of the Adapt plus Study (Meeting Abstract) |
Autori | Howard James F Jr Bril Vera Tuan Vu Karam Chafic Peric Stojan Z ![]() |
Info | MUSCLE & NERVE, (2022), vol. 65 br. , Suppl. 1, str. S9-S10 |
Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|
Naslov | Efficacy, Safety, and Tolerability of Efgartigimod in Patients With Generalized Myasthenia Gravis: Analysis of the Phase 3 ADAPT Study (Meeting Abstract) |
Autori | Howard James Bril Vera Vu Tuan Karam Chafic Peric Stojan Z ![]() |
Info | NEUROLOGY, (2021), vol. 96 br. 15, Suppl. S, str. - |
Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science Scopus |
|
Naslov | Analysis of Efgartigimod Efficacy Across Patient Populations and Myasthenia Gravis Specific Scales: Results of the Phase 3 ADAPT Study (Meeting Abstract) |
Autori | Bril Vera ... Peric Stojan Z ![]() |
Info | ANNALS OF NEUROLOGY, (2021), vol. 90 br. , Suppl. 27, str. S28-S28 |
Ispravka | Web of Science Elečas Rang časopisa Citati: Web of Science |
|